Rothwell Investment Advisors, LLC’s GSK GSK Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$57.6K	Buy	+1,196	New	+$61.1K	0.03%	398

Other funds holding GSK

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return

Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Rothwell Investment Advisors, LLC's GSK Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in GSK (GSK) in Q3 2026: 1,196 shares worth $57.6K. The stake represents 0.03% of the portfolio and ranks #398 among its holdings.

558 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Rothwell Investment Advisors, LLC held 1,196 shares of GSK worth $57.6K as of Q3 2026.
GSK was a new Rothwell Investment Advisors, LLC position in Q3 2026.
GSK made up 0.03% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #398 holding.
558 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.